Partnerships in Drug Discovery

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-01-2001
Volume 2001 Supplement
Issue 2

To maximize the value of outsourcing, pharmaceutical and biotech companies are realizing the importance of close partnerships with their contract service providers.

External Link - article-5149.pdf

Articles in this issue
Creating a Successful Partnership with a Contract Manufacturer
Outsourcing Outlook
Creative Solutions in Client-CRO Relationships
Third-Party Technology Transfer
The Squeeze in Contract Manufacturing
Preparing Requests for Quotations for Commercial Pharmaceutical Manufacturing
Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies
Stakes Rise for Blown Batches
Partnerships in Drug Discovery
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Drug Digest: Strategic Partnerships
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

Susan Haigney
June 27th 2025
Article

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

Susan Haigney
June 25th 2025
Article

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 2nd 2023
Podcast

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Cancer detection and screening as a treatment for malignant cells with a biopsy or testing caused by carcinogens and genetics with a cancerous cell as an immunotherapy symbol | Image Credit: © freshidea - stock.adobe.com

Mabion Announces Oncology Services Contest at BIO 2025

Patrick Lavery
June 18th 2025
Article

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI Frankfurt in October 2025.

South San Francisco, CA, USA - February 24, 2021: Closeup of a AstraZeneca building corporate office, a British-Swedish pharmaceutical, biotechnology company with its headquarters in Cambridge, England | Image Credit: © Valeriya Zankovych - stock.adobe.com

AstraZeneca Partners on AI-Enabled Research with CSPC Pharmaceuticals

Patrick Lavery
June 13th 2025
Article

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.